Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
Top Cited Papers
Open Access
- 11 August 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Structural & Molecular Biology
- Vol. 28 (9), 740-746
- https://doi.org/10.1038/s41594-021-00651-0
Abstract
Molnupiravir is an orally available antiviral drug candidate currently in phase III trials for the treatment of patients with COVID-19. Molnupiravir increases the frequency of viral RNA mutations and impairs SARS-CoV-2 replication in animal models and in humans. Here, we establish the molecular mechanisms underlying molnupiravir-induced RNA mutagenesis by the viral RNA-dependent RNA polymerase (RdRp). Biochemical assays show that the RdRp uses the active form of molnupiravir, β-d-N4-hydroxycytidine (NHC) triphosphate, as a substrate instead of cytidine triphosphate or uridine triphosphate. When the RdRp uses the resulting RNA as a template, NHC directs incorporation of either G or A, leading to mutated RNA products. Structural analysis of RdRp–RNA complexes that contain mutagenesis products shows that NHC can form stable base pairs with either G or A in the RdRp active center, explaining how the polymerase escapes proofreading and synthesizes mutated RNA. This two-step mutagenesis mechanism probably applies to various viral polymerases and can explain the broad-spectrum antiviral activity of molnupiravir.Keywords
This publication has 63 references indexed in Scilit:
- Synthesis of spin-labeled riboswitch RNAs using convertible nucleosides and DNA-catalyzed RNA ligationBioorganic & Medicinal Chemistry, 2013
- Antiviral Activity of Nucleoside Analogues against NorovirusAntiviral Therapy, 2012
- RNA 3'-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complexProceedings of the National Academy of Sciences of the United States of America, 2012
- Features and development of CootActa crystallographica. Section D, Structural biology, 2010
- electronic Ligand Builder and Optimization Workbench(eLBOW): a tool for ligand coordinate and restraint generationActa crystallographica. Section D, Structural biology, 2009
- Template properties of mutagenic cytosine analogues in reverse transcriptionNucleic Acids Research, 2006
- Automated electron microscope tomography using robust prediction of specimen movementsJournal of Structural Biology, 2005
- Ribonucleoside Analogue That Blocks Replication of Bovine Viral Diarrhea and Hepatitis C Viruses in CultureAntimicrobial Agents and Chemotherapy, 2003
- RNA virus error catastrophe: Direct molecular test by using ribavirinProceedings of the National Academy of Sciences of the United States of America, 2001
- Structure and conformation of N4-hydroxycytosine and N4-hydroxy-5-fluorocytosine. A theoretical ab initio studyBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1993